Transcutaneous Neurostimulator

The "Ducest Neurostimulator V" (DNS-V) is a Class 2a neurostimulator that is approved for the treatment of peripheral arterial disease (PAD) and pain. It is minimally invasive. The DNS-V device is compact and barely noticeable in everyday life, making it easy for the doctor to attach it to the patient. Additionally, its water resistance allows it to be worn during daily personal care.input:
output:The afferent pathway is the primary focus of DNS-V therapy, which is a novel approach. The therapy, which is based on the research of Austrian Nobel Prize winner Eric Kandel on the Aplysia, a Californian sea snail, is designed to enhance the activity of the sensory (afferent) nuclei by continuously stimulating afferent nerve pathways.



The unique function of the GAN and afferent nerve pathways in the ear



According to a literature search conducted by Dr. Hirtler of the Anatomical Institute of the University of Vienna, all nerves in the ear are exclusively afferent nerve pathways. The greater auricular branch (GAN) is a unique nerve that is crucial to this therapy. This extends from the fossa triangularis, over the C2 and C3 vertebrae, to the nucleus tractus solitarii. It is intriguing that this nucleus also shares a pathway with the vagus nerve.



A promising method of brainstem stimulation is the stimulation of the GAN. No decrease in heart rate has been observed thus far in comparison to vagus stimulation, which may represent a potential advantage.input:
output:Novel therapeutic strategies for medicine: DNS-V therapyinput:
output:DNS-V therapy provides a straightforward and low-stress approach for a variety of applications. Two critical indicators are as follows: